Navigation Links
Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know"
Date:12/1/2011

PLANO, Texas, Dec. 1, 2011 /PRNewswire-iReach/ -- Physicians' Capital Investments, LLC (PCI/the Company) a leader in medical real estate development and medical investment solutions is pleased to announce that Becker's ASC Review has named Pedro Vergne-Marini, MD to its publication, "350 People in the ASC Industry to Know." This publication recognizes the leaders who shape the ambulatory surgery center industry through their work with ASC-related companies, surgery centers and physician practices.  

(Photo:  http://photos.prnewswire.com/prnh/20111201/CG15872)

The leaders named to this list contribute to surgery center companies, Ambulatory Surgery Centers (ASCs) and physician practices in a number of different ways. Some are company executives who grow their operations through careful strategic planning; others are surgery center administrators who strive on a daily basis to improve patient care and bolster profitability. The list includes surgery center physicians who pioneer cutting-edge procedures in the ambulatory setting, as well as association leaders who lobby for surgery centers on a local and national level.  

The full-length version of this list can be found online at:

http://www.beckersasc.com/lists/350-people-in-the-asc-industry-to-know.html?utm_source=directemail&utm_medium=pressrelease&utm_campaign=350%2Bpeople%2Bto%2Bknow%2B2011

Pedro Vergne-Marini's, MD profile can be found at:

http://www.beckersasc.com/lists/350-people-in-the-asc-industry-to-know-part-2/350-people-in-the-asc-industry-to-know-v.html

"In 2011 PCI made the business decision to expand its unique financing and development model to the ASC medical modality. Within a short period of time, PCI has received a lot of interest and support within the ASC medical community for its services. Due to the latter, PCI will be announcing the groundbreaking of several ASC de novo developments in CY 2012. PCI is honored to have one of its founding members named to '350 People in the ASC Industry to Know' and further demonstrates our in-depth understanding of the ASC medical modality," said Pedro Juan Vergne-Morell, PCI's President and Chief Executive Officer.

About Becker's ASC Review

Becker's ASC Review features general business, legal and clinical guidance on topics including joint-ventures, development and expansion, and regulatory and compliance issues; as well as analysis and insight for specialties including bariatrics, orthopedics/spine, gastroenterology, neurosurgery, pain management, ophthalmology, ENT and anesthesiology. Each of the nine annual issues of the publication reaches a qualified audience of more than 25,000 key business decision-holders, including surgeons, medical directors, directors of surgery, ASC administrators and others involved in the rapidly growing field of outpatient surgery. Further, every ASC in the nation receives Becker's ASC Review.

About Physicians' Capital Investments, LLC (PCI)

Founded in 2007, PCI has over 100 years of combined medical construction/development, clinical care and healthcare management experience. Over the last four years, PCI has successfully developed customized, high-quality, modern and efficient medical office and clinical facilities across the United States. PCI guides each project by providing ongoing expertise in project management, development, financing, lease negotiations, facility and investment management services. Typically, PCI provides a unique opportunity for individual physicians and their employees to purchase medical and clinical facilities while limiting liability. PCI is owned in part by physicians; which inspires the Company's tagline "Physicians Investing in Physicians." In addition to its Plano headquarters office, PCI also maintains a regional office at 1225 Seventeenth St., Suite 1750, Denver CO 80202. For more information on PCI, please visit www.physcap.com.

This release may contain "forward-looking statements". All statements, other than statements of historical fact, including statements that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results may differ significantly from those envisaged by our forward-looking statements. Among the factors that could cause actual results to differ materially from those described or implied in the forward-looking statements are general business and economic conditions, production delays resulting from lack of regulatory certifications and other factors, competition in our existing and future markets, lack of market acceptance of our products and services, the substantial leverage and debt service resulting from our indebtedness, loss or retirement of key executives and other risks disclosed by us or generally associated with our business.

Media Contact: P.J. Vergne-Morell Physicians' Capital Investments, 866-936-3089, PJVergne@physcap.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Physicians’ Capital Investments, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Physicians Will Benefit from Medical Software Advice Website
5. Physicians Reconsider Implications of Enhance Trial
6. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
7. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
8. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
9. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
10. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
11. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... -- Companion animal vaccines are ... such as canine, avian and feline. ... as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, ... Vaccines. Attenuated live vaccines are derived from disease-causing ... been weakend under laboratory conditions. Conjugate vaccines are ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... breakthrough topical cream that’s the first in a new class of photodynamic cosmetics ... overall appearance of skin, visibly reduce outward signs of aging, and minimize the ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a leading provider of ... management module. Using this new feature, sleep physicians can now predict the likelihood ... positive airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The ...
Breaking Medicine News(10 mins):